Bluebird Bio | Ventes



Ventes Changement Date
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amgen USD 9.9B 340M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Gilead Sciences USD 7.93B 130M 2025-12
Incyte USD 1.51B 140M 2025-12
Ionis Pharmaceuticals USD 157M 295M 2025-09
Moderna USD 678M 342M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Novartis USD 13.91B 144M 2025-09
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12


Bluebird Bio Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.